SlideShare a Scribd company logo
1 of 19
Originally Presented by Dr. Marissa Capette
Dr Jeku Jacob and CNC Lisa-Jayne Ferguson
Drug & Alcohol Service
St Vincent’s Hospital
Benzodiazepines
Effects,
Withdrawal &
Treatment Options
BZD’s - Introduction
 The most widely used of all psychotropic drugs
 Treatment of
 Anxiety states
 Muscle spasm/ tension
 Seizures
 Insomnia
 Safer than barbiturates (less chance of OD)
 However dependence can develop (3 weeks)
– tolerance and withdrawal
BZD’S ARE USED BY 2 MAIN GROUPS
 Elderly & women (low dose)
 Young, polysubstance users (high dose)
WHY PEOPLE USE BZD?
Enhance & prolong the 'high‘ of other drugs
Alleviate withdrawal effects
Users of stimulants take benzodiazepines as
'downers'
The mixture of alcohol and benzodiazepines
produces a hedonic effect
BZD Intoxication
 Decreased anxiety
 Sleepiness
 Sedation
 Anti-convulsant effects
 Blurred vision
 Poor memory recall
 Dizziness/vertigo
 Confusion
 Slurred speech
 Ataxia, poor motor co-
ordination
 Stupor
 Paradoxical violence and
disinhibited behaviour
BZD INTOXICATION
 Dose dependant
 Sedation Stupor
Respiratory depression
 Death can result if taken with
other drugs
Health & social hazards of BZD misuse
General
Complications
of IV use
Fatalities due to overdose (particularly in
combination with opioids)
Thrombophlebitis
Blackouts and memory loss Deep and superficial abscesses
Paranoia Deep vein thrombosis
Violence and criminal behaviour Pulmonary microembolism
Risk-taking sexual behaviour Rhabdomyolysis, tissue necrosis
Foetal and neonatal risks if taken in pregnancy
Gangrene, requiring amputation (usually
due to inadvertent intra-arterial
injection)
Dependence Hepatitis B and C
Withdrawal seizures HIV infection
Comparison Table
Trade names Time to peak Half life
Diazepam Valium, Ducene,
Antenex
30-90 mins 20-48 hrs
Temazepam Temaze, Normison 30-60 mins 5-15hrs
Oxazepam Serepax, Murelax 2-3 hrs 4-15 hrs
Alprazolam Xanax, Kalma 1 hr 6-25 hrs
Lorazepam Ativan 2 hrs 12-16 hrs
Clonazepam Ritrovivl, Paxam 2-3 hrs 22-54 hrs
Benzodiazepine Equivalence
5 mg Diazepam equal to –
– Alprazolam 0.5-1 mg
– Temazepam 10-20 mg
– Clonazepam 0.5 mg
– Oxazepam 15 mg
– Lorazepam 1 mg
Adapted from Frank L, Pead J. New concepts in drug withdrawal: a
resource handbook © 1995 State of Victoria.
Withdrawal Profile
Withdrawal Symptoms
 Rebound anxiety (particularly with short acting)
 Insomnia
 Poor concentration and memory
 Muscle aches, stiffness and spasms
 Tremor, sweats
 Racing thoughts, agitation
 Confusion
 Depression
 Increased sensory perception → hallucinations
 Delirium
 Seizures
Signs of Withdrawal
 Withdrawals featuring a delirium can mimic
amphetamine intoxication or psychotic episode 2nd
to underlying Mental Health issues
 Pupils dilated and fine tremor may indicate
Benzodiazepine withdrawal
Assessment
Duration
Amount
Street or GP (phone)
Regularity of use, binge etc...
Does the pt wish to change intake?
In-Pt Withdrawal Treatment
 Convert short acting regular BZD dose to long acting
BZD (Diazepam)
 Patient stabilised at a dose of 40% of their regular
intake (or 80 mg/day whichever is lower) in 3 - 4
divided doses
 Day 5 onwards – Reduce by 10% every 2-4/7’s,
depending on pt’s response
Community Withdrawal Treatment
 Reduce by 10 mg / week until 40 mg
 Then by 5mg / week
 This will take about 12 weeks
 Supportive GP
 Pick up from pharmacy
 Pt can sign Dr Shopping form
Withdrawal Symptoms
Withdrawal symptoms do not decrease steadily
from a peak, but follow a fluctuating course with
good & bad periods
Eventually the good periods will last longer &
become more frequent
Abrupt or over-rapid withdrawal, especially from
high dosage, can give rise to severe symptoms
(convulsions, psychotic reactions, acute anxiety
states)
New South Wales Drug and Alcohol Withdrawal
Clinical Practice Guidelines (2007)
Treatment Options
 Detox / Rehabilitation (Limited facilities)
 Self Management & Recovery Training (SMART)
 Narcotics Anonymous/ 12 Step programme
 Individual Counselling
 Alcohol & Drug Information Service - 93618000 or local
area A&D service
Benzodiazepine Overdose: Treatment
 Monitor vitals & O2 sats
 Charcoal/Osmotic Purgative if recent ingestion
 Flumazenil – Benzodiazepine antagonist (0.2 mg/min IV
initially, repeat up to 3 mg maximum)
 Caution in patients where Benzodiazepine dependence is
suspected: risk of Benzodiazepine withdrawal seizure
Case Study
 58 year old female admitted to hospital after chest
pain
 On day 4, patient suffered two grand mal seizures.
 Pt known to be alcohol dependant
 Pt suspected of abusing benzodiazepenes
 Refused to admit to more than 10 mg/ night.

More Related Content

What's hot

Conventional Antipsychotics 2 19 2007
Conventional Antipsychotics 2 19 2007Conventional Antipsychotics 2 19 2007
Conventional Antipsychotics 2 19 2007Flavio Guzmán
 
Quetiapine (Anti psychotic medicine)
Quetiapine (Anti psychotic medicine)Quetiapine (Anti psychotic medicine)
Quetiapine (Anti psychotic medicine)usra_ashraf
 
Anti anxiety ppt
Anti anxiety pptAnti anxiety ppt
Anti anxiety pptSohil Shah
 
Amisulpride@ use in psychotic illnesses
Amisulpride@ use in psychotic illnessesAmisulpride@ use in psychotic illnesses
Amisulpride@ use in psychotic illnessesSujit Kumar Kar
 
Parkinsonism treatment
Parkinsonism treatmentParkinsonism treatment
Parkinsonism treatmentNaser Tadvi
 
CASE ON BENZODIAZEPINE POISONING
CASE ON BENZODIAZEPINE POISONINGCASE ON BENZODIAZEPINE POISONING
CASE ON BENZODIAZEPINE POISONINGSUNIL NAYAK
 
Quetiapine for Borderline Personality Disorder
Quetiapine for Borderline Personality DisorderQuetiapine for Borderline Personality Disorder
Quetiapine for Borderline Personality DisorderAzimatul Karimah
 
Understanding Xanax (Alprazolam) 1mg , What Is Alprazolam?
Understanding Xanax (Alprazolam) 1mg , What Is Alprazolam? Understanding Xanax (Alprazolam) 1mg , What Is Alprazolam?
Understanding Xanax (Alprazolam) 1mg , What Is Alprazolam? Health Care culb
 
Psychotropic Drug Treatment2
Psychotropic Drug Treatment2Psychotropic Drug Treatment2
Psychotropic Drug Treatment2Dr. Drew Chenelly
 
Antianxiety drugs pharmacology
Antianxiety drugs pharmacologyAntianxiety drugs pharmacology
Antianxiety drugs pharmacologyPranatiChavan
 
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)Sawsan Aboul-Fotouh
 

What's hot (19)

anxiolytics
anxiolyticsanxiolytics
anxiolytics
 
Anti-anxiety drugs
Anti-anxiety drugsAnti-anxiety drugs
Anti-anxiety drugs
 
Conventional Antipsychotics 2 19 2007
Conventional Antipsychotics 2 19 2007Conventional Antipsychotics 2 19 2007
Conventional Antipsychotics 2 19 2007
 
Quetiapine (Anti psychotic medicine)
Quetiapine (Anti psychotic medicine)Quetiapine (Anti psychotic medicine)
Quetiapine (Anti psychotic medicine)
 
Anti anxiety ppt
Anti anxiety pptAnti anxiety ppt
Anti anxiety ppt
 
Antianxiety
AntianxietyAntianxiety
Antianxiety
 
Amisulpride@ use in psychotic illnesses
Amisulpride@ use in psychotic illnessesAmisulpride@ use in psychotic illnesses
Amisulpride@ use in psychotic illnesses
 
Parkinsonism treatment
Parkinsonism treatmentParkinsonism treatment
Parkinsonism treatment
 
Cognitive enhancers and_more2
Cognitive enhancers and_more2Cognitive enhancers and_more2
Cognitive enhancers and_more2
 
CASE ON BENZODIAZEPINE POISONING
CASE ON BENZODIAZEPINE POISONINGCASE ON BENZODIAZEPINE POISONING
CASE ON BENZODIAZEPINE POISONING
 
antidepressants and anxiolytics
antidepressants and anxiolyticsantidepressants and anxiolytics
antidepressants and anxiolytics
 
Quetiapine for Borderline Personality Disorder
Quetiapine for Borderline Personality DisorderQuetiapine for Borderline Personality Disorder
Quetiapine for Borderline Personality Disorder
 
Antianxiety drugs
Antianxiety drugsAntianxiety drugs
Antianxiety drugs
 
Understanding Xanax (Alprazolam) 1mg , What Is Alprazolam?
Understanding Xanax (Alprazolam) 1mg , What Is Alprazolam? Understanding Xanax (Alprazolam) 1mg , What Is Alprazolam?
Understanding Xanax (Alprazolam) 1mg , What Is Alprazolam?
 
Psychotropic Drug Treatment2
Psychotropic Drug Treatment2Psychotropic Drug Treatment2
Psychotropic Drug Treatment2
 
Antianxiety drugs pharmacology
Antianxiety drugs pharmacologyAntianxiety drugs pharmacology
Antianxiety drugs pharmacology
 
Anti parkinsonian
Anti parkinsonianAnti parkinsonian
Anti parkinsonian
 
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
 
Selective serotonin
Selective serotoninSelective serotonin
Selective serotonin
 

Viewers also liked

Peripheral Benzodiazepine Receptors
Peripheral Benzodiazepine  ReceptorsPeripheral Benzodiazepine  Receptors
Peripheral Benzodiazepine ReceptorsMichael M
 
Promoting the safe management of people with Severe Mental Illness by trainin...
Promoting the safe management of people with Severe Mental Illness by trainin...Promoting the safe management of people with Severe Mental Illness by trainin...
Promoting the safe management of people with Severe Mental Illness by trainin...Mental Health Partnerships
 
7.b. sedative hypnotics
7.b. sedative hypnotics 7.b. sedative hypnotics
7.b. sedative hypnotics IAU Dent
 
Intoxicacion por benzodiacepinas
Intoxicacion por benzodiacepinasIntoxicacion por benzodiacepinas
Intoxicacion por benzodiacepinasLidsay Uh
 
Seizure Ppt Etc
Seizure Ppt EtcSeizure Ppt Etc
Seizure Ppt Etcmycomic
 
Sedative-Hypnotic Drugs
Sedative-Hypnotic DrugsSedative-Hypnotic Drugs
Sedative-Hypnotic Drugsshabeel pn
 

Viewers also liked (8)

Seizure
SeizureSeizure
Seizure
 
Peripheral Benzodiazepine Receptors
Peripheral Benzodiazepine  ReceptorsPeripheral Benzodiazepine  Receptors
Peripheral Benzodiazepine Receptors
 
Promoting the safe management of people with Severe Mental Illness by trainin...
Promoting the safe management of people with Severe Mental Illness by trainin...Promoting the safe management of people with Severe Mental Illness by trainin...
Promoting the safe management of people with Severe Mental Illness by trainin...
 
7.b. sedative hypnotics
7.b. sedative hypnotics 7.b. sedative hypnotics
7.b. sedative hypnotics
 
Toxicología de la benzodiacepinas v2
Toxicología de la benzodiacepinas v2Toxicología de la benzodiacepinas v2
Toxicología de la benzodiacepinas v2
 
Intoxicacion por benzodiacepinas
Intoxicacion por benzodiacepinasIntoxicacion por benzodiacepinas
Intoxicacion por benzodiacepinas
 
Seizure Ppt Etc
Seizure Ppt EtcSeizure Ppt Etc
Seizure Ppt Etc
 
Sedative-Hypnotic Drugs
Sedative-Hypnotic DrugsSedative-Hypnotic Drugs
Sedative-Hypnotic Drugs
 

Similar to Bzd 2012[1]

Antianxietydrugs 160402025443
Antianxietydrugs 160402025443Antianxietydrugs 160402025443
Antianxietydrugs 160402025443Mahi Yeruva
 
Clinical pharmacology of sedative hypnotics
Clinical pharmacology of sedative hypnoticsClinical pharmacology of sedative hypnotics
Clinical pharmacology of sedative hypnoticsDomina Petric
 
Class anti depressants
Class anti depressantsClass anti depressants
Class anti depressantsRaghu Prasada
 
Class antidepressants, antimaniacs, cns stimulants
Class antidepressants, antimaniacs, cns stimulantsClass antidepressants, antimaniacs, cns stimulants
Class antidepressants, antimaniacs, cns stimulantsRaghu Prasada
 
Anti depressant drugs
Anti depressant drugsAnti depressant drugs
Anti depressant drugsRaghu Prasada
 
Psychopharmacology-copy.pptx
Psychopharmacology-copy.pptxPsychopharmacology-copy.pptx
Psychopharmacology-copy.pptxDexterNicolas2
 
2. treatment of_anxiety_disorders_angel_
2. treatment of_anxiety_disorders_angel_2. treatment of_anxiety_disorders_angel_
2. treatment of_anxiety_disorders_angel_Abed8k
 
Anxiolytic & Hypnotic Drugs
Anxiolytic & Hypnotic DrugsAnxiolytic & Hypnotic Drugs
Anxiolytic & Hypnotic DrugsLabeed Ahmed
 
Antianxiety drugs symptoms and pharmacology
Antianxiety drugs  symptoms and pharmacologyAntianxiety drugs  symptoms and pharmacology
Antianxiety drugs symptoms and pharmacologySreenivasa Reddy Thalla
 
Sedatives and hypnotics
Sedatives and hypnoticsSedatives and hypnotics
Sedatives and hypnoticsDu'a Al-Zu'bi
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnoticsChintan Doshi
 
Management of movement disorders
Management of movement disordersManagement of movement disorders
Management of movement disordersRavi Soni
 

Similar to Bzd 2012[1] (20)

Antianxietydrugs 160402025443
Antianxietydrugs 160402025443Antianxietydrugs 160402025443
Antianxietydrugs 160402025443
 
Clinical pharmacology of sedative hypnotics
Clinical pharmacology of sedative hypnoticsClinical pharmacology of sedative hypnotics
Clinical pharmacology of sedative hypnotics
 
Class anti depressants
Class anti depressantsClass anti depressants
Class anti depressants
 
Class antidepressants, antimaniacs, cns stimulants
Class antidepressants, antimaniacs, cns stimulantsClass antidepressants, antimaniacs, cns stimulants
Class antidepressants, antimaniacs, cns stimulants
 
Anti depressant drugs
Anti depressant drugsAnti depressant drugs
Anti depressant drugs
 
Psychopharmacology-copy.pptx
Psychopharmacology-copy.pptxPsychopharmacology-copy.pptx
Psychopharmacology-copy.pptx
 
2. treatment of_anxiety_disorders_angel_
2. treatment of_anxiety_disorders_angel_2. treatment of_anxiety_disorders_angel_
2. treatment of_anxiety_disorders_angel_
 
Anxiolytic & Hypnotic Drugs
Anxiolytic & Hypnotic DrugsAnxiolytic & Hypnotic Drugs
Anxiolytic & Hypnotic Drugs
 
Antianxiety drugs symptoms and pharmacology
Antianxiety drugs  symptoms and pharmacologyAntianxiety drugs  symptoms and pharmacology
Antianxiety drugs symptoms and pharmacology
 
Anti-anxiety drugs.pptx
Anti-anxiety drugs.pptxAnti-anxiety drugs.pptx
Anti-anxiety drugs.pptx
 
Ati 2
Ati 2Ati 2
Ati 2
 
Sedatives and hypnotics
Sedatives and hypnoticsSedatives and hypnotics
Sedatives and hypnotics
 
Psychotropic Medications & Their Side Effects
Psychotropic Medications & Their Side EffectsPsychotropic Medications & Their Side Effects
Psychotropic Medications & Their Side Effects
 
Drug abuse
Drug abuseDrug abuse
Drug abuse
 
Anti-Anxiety drugs
Anti-Anxiety drugs Anti-Anxiety drugs
Anti-Anxiety drugs
 
Icu pharm case
Icu pharm caseIcu pharm case
Icu pharm case
 
Icu pharm case
Icu pharm caseIcu pharm case
Icu pharm case
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
 
PSYCHO PHARMACOLOGY.pptx
PSYCHO PHARMACOLOGY.pptxPSYCHO PHARMACOLOGY.pptx
PSYCHO PHARMACOLOGY.pptx
 
Management of movement disorders
Management of movement disordersManagement of movement disorders
Management of movement disorders
 

More from Jeku Jacob

Opioid withdrawal update3[1]
Opioid withdrawal update3[1]Opioid withdrawal update3[1]
Opioid withdrawal update3[1]Jeku Jacob
 
Fwd: Bambury Tutorial on Head and Neck
Fwd: Bambury Tutorial on Head and NeckFwd: Bambury Tutorial on Head and Neck
Fwd: Bambury Tutorial on Head and NeckJeku Jacob
 
Fwd: Post op complications
Fwd: Post op complicationsFwd: Post op complications
Fwd: Post op complicationsJeku Jacob
 
Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)Jeku Jacob
 
Fwd: Head injury Bambury
Fwd: Head injury BamburyFwd: Head injury Bambury
Fwd: Head injury BamburyJeku Jacob
 
Fwd: Diverticular Disease
Fwd: Diverticular DiseaseFwd: Diverticular Disease
Fwd: Diverticular DiseaseJeku Jacob
 
Fwd: Bambury lecture on venous and lymphatic disorders of the limb
Fwd: Bambury lecture on venous and lymphatic disorders of the limbFwd: Bambury lecture on venous and lymphatic disorders of the limb
Fwd: Bambury lecture on venous and lymphatic disorders of the limbJeku Jacob
 
Fwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessmentFwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessmentJeku Jacob
 
Fwd: Bambury tutorial Upper GI Surgery
Fwd: Bambury tutorial Upper GI SurgeryFwd: Bambury tutorial Upper GI Surgery
Fwd: Bambury tutorial Upper GI SurgeryJeku Jacob
 
Fwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. EvoyFwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. EvoyJeku Jacob
 
Fwd: Thyroid Surgery (Cormac Joyce)
Fwd: Thyroid Surgery (Cormac Joyce)Fwd: Thyroid Surgery (Cormac Joyce)
Fwd: Thyroid Surgery (Cormac Joyce)Jeku Jacob
 
Fwd: Cardiothoracic surgery Bambury
Fwd: Cardiothoracic surgery BamburyFwd: Cardiothoracic surgery Bambury
Fwd: Cardiothoracic surgery BamburyJeku Jacob
 
Upper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) BamburyUpper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) BamburyJeku Jacob
 
Fwd: Wound Healing
Fwd: Wound HealingFwd: Wound Healing
Fwd: Wound HealingJeku Jacob
 

More from Jeku Jacob (17)

Opioid withdrawal update3[1]
Opioid withdrawal update3[1]Opioid withdrawal update3[1]
Opioid withdrawal update3[1]
 
Etoh[1]
Etoh[1]Etoh[1]
Etoh[1]
 
Fwd: Bambury Tutorial on Head and Neck
Fwd: Bambury Tutorial on Head and NeckFwd: Bambury Tutorial on Head and Neck
Fwd: Bambury Tutorial on Head and Neck
 
Fwd: lecture
Fwd: lectureFwd: lecture
Fwd: lecture
 
Fwd: Post op complications
Fwd: Post op complicationsFwd: Post op complications
Fwd: Post op complications
 
Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)Fwd: Skin Cancer (Cormac Joyce)
Fwd: Skin Cancer (Cormac Joyce)
 
Fwd: Head injury Bambury
Fwd: Head injury BamburyFwd: Head injury Bambury
Fwd: Head injury Bambury
 
Fwd: Jaundice
Fwd: JaundiceFwd: Jaundice
Fwd: Jaundice
 
Fwd: Diverticular Disease
Fwd: Diverticular DiseaseFwd: Diverticular Disease
Fwd: Diverticular Disease
 
Fwd: Bambury lecture on venous and lymphatic disorders of the limb
Fwd: Bambury lecture on venous and lymphatic disorders of the limbFwd: Bambury lecture on venous and lymphatic disorders of the limb
Fwd: Bambury lecture on venous and lymphatic disorders of the limb
 
Fwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessmentFwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessment
 
Fwd: Bambury tutorial Upper GI Surgery
Fwd: Bambury tutorial Upper GI SurgeryFwd: Bambury tutorial Upper GI Surgery
Fwd: Bambury tutorial Upper GI Surgery
 
Fwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. EvoyFwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. Evoy
 
Fwd: Thyroid Surgery (Cormac Joyce)
Fwd: Thyroid Surgery (Cormac Joyce)Fwd: Thyroid Surgery (Cormac Joyce)
Fwd: Thyroid Surgery (Cormac Joyce)
 
Fwd: Cardiothoracic surgery Bambury
Fwd: Cardiothoracic surgery BamburyFwd: Cardiothoracic surgery Bambury
Fwd: Cardiothoracic surgery Bambury
 
Upper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) BamburyUpper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) Bambury
 
Fwd: Wound Healing
Fwd: Wound HealingFwd: Wound Healing
Fwd: Wound Healing
 

Recently uploaded

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersChitralekhaTherkar
 

Recently uploaded (20)

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of Powders
 

Bzd 2012[1]

  • 1. Originally Presented by Dr. Marissa Capette Dr Jeku Jacob and CNC Lisa-Jayne Ferguson Drug & Alcohol Service St Vincent’s Hospital Benzodiazepines Effects, Withdrawal & Treatment Options
  • 2. BZD’s - Introduction  The most widely used of all psychotropic drugs  Treatment of  Anxiety states  Muscle spasm/ tension  Seizures  Insomnia  Safer than barbiturates (less chance of OD)  However dependence can develop (3 weeks) – tolerance and withdrawal
  • 3. BZD’S ARE USED BY 2 MAIN GROUPS  Elderly & women (low dose)  Young, polysubstance users (high dose)
  • 4. WHY PEOPLE USE BZD? Enhance & prolong the 'high‘ of other drugs Alleviate withdrawal effects Users of stimulants take benzodiazepines as 'downers' The mixture of alcohol and benzodiazepines produces a hedonic effect
  • 5. BZD Intoxication  Decreased anxiety  Sleepiness  Sedation  Anti-convulsant effects  Blurred vision  Poor memory recall  Dizziness/vertigo  Confusion  Slurred speech  Ataxia, poor motor co- ordination  Stupor  Paradoxical violence and disinhibited behaviour
  • 6. BZD INTOXICATION  Dose dependant  Sedation Stupor Respiratory depression  Death can result if taken with other drugs
  • 7. Health & social hazards of BZD misuse General Complications of IV use Fatalities due to overdose (particularly in combination with opioids) Thrombophlebitis Blackouts and memory loss Deep and superficial abscesses Paranoia Deep vein thrombosis Violence and criminal behaviour Pulmonary microembolism Risk-taking sexual behaviour Rhabdomyolysis, tissue necrosis Foetal and neonatal risks if taken in pregnancy Gangrene, requiring amputation (usually due to inadvertent intra-arterial injection) Dependence Hepatitis B and C Withdrawal seizures HIV infection
  • 8. Comparison Table Trade names Time to peak Half life Diazepam Valium, Ducene, Antenex 30-90 mins 20-48 hrs Temazepam Temaze, Normison 30-60 mins 5-15hrs Oxazepam Serepax, Murelax 2-3 hrs 4-15 hrs Alprazolam Xanax, Kalma 1 hr 6-25 hrs Lorazepam Ativan 2 hrs 12-16 hrs Clonazepam Ritrovivl, Paxam 2-3 hrs 22-54 hrs
  • 9. Benzodiazepine Equivalence 5 mg Diazepam equal to – – Alprazolam 0.5-1 mg – Temazepam 10-20 mg – Clonazepam 0.5 mg – Oxazepam 15 mg – Lorazepam 1 mg
  • 10. Adapted from Frank L, Pead J. New concepts in drug withdrawal: a resource handbook © 1995 State of Victoria. Withdrawal Profile
  • 11. Withdrawal Symptoms  Rebound anxiety (particularly with short acting)  Insomnia  Poor concentration and memory  Muscle aches, stiffness and spasms  Tremor, sweats  Racing thoughts, agitation  Confusion  Depression  Increased sensory perception → hallucinations  Delirium  Seizures
  • 12. Signs of Withdrawal  Withdrawals featuring a delirium can mimic amphetamine intoxication or psychotic episode 2nd to underlying Mental Health issues  Pupils dilated and fine tremor may indicate Benzodiazepine withdrawal
  • 13. Assessment Duration Amount Street or GP (phone) Regularity of use, binge etc... Does the pt wish to change intake?
  • 14. In-Pt Withdrawal Treatment  Convert short acting regular BZD dose to long acting BZD (Diazepam)  Patient stabilised at a dose of 40% of their regular intake (or 80 mg/day whichever is lower) in 3 - 4 divided doses  Day 5 onwards – Reduce by 10% every 2-4/7’s, depending on pt’s response
  • 15. Community Withdrawal Treatment  Reduce by 10 mg / week until 40 mg  Then by 5mg / week  This will take about 12 weeks  Supportive GP  Pick up from pharmacy  Pt can sign Dr Shopping form
  • 16. Withdrawal Symptoms Withdrawal symptoms do not decrease steadily from a peak, but follow a fluctuating course with good & bad periods Eventually the good periods will last longer & become more frequent Abrupt or over-rapid withdrawal, especially from high dosage, can give rise to severe symptoms (convulsions, psychotic reactions, acute anxiety states) New South Wales Drug and Alcohol Withdrawal Clinical Practice Guidelines (2007)
  • 17. Treatment Options  Detox / Rehabilitation (Limited facilities)  Self Management & Recovery Training (SMART)  Narcotics Anonymous/ 12 Step programme  Individual Counselling  Alcohol & Drug Information Service - 93618000 or local area A&D service
  • 18. Benzodiazepine Overdose: Treatment  Monitor vitals & O2 sats  Charcoal/Osmotic Purgative if recent ingestion  Flumazenil – Benzodiazepine antagonist (0.2 mg/min IV initially, repeat up to 3 mg maximum)  Caution in patients where Benzodiazepine dependence is suspected: risk of Benzodiazepine withdrawal seizure
  • 19. Case Study  58 year old female admitted to hospital after chest pain  On day 4, patient suffered two grand mal seizures.  Pt known to be alcohol dependant  Pt suspected of abusing benzodiazepenes  Refused to admit to more than 10 mg/ night.